Quantenna Communications racks up $22 mln

By Iris Dorbian — 1 year ago

Silicon Valley-based Wi-Fi solutions provider Quantenna Communications has closed $22 million in funding. The lead investors were Centerview Capital Technology, Vivint and NTT Group. Return backers Sequoia Capital, DAG Ventures, Rusnano, Sigma Partners and Venrock also participated in the round. In addition to the financing, Quantenna has named Ned Hooper and Harold Hughes to its board of directors.


Egros Appointed COO of NovaMedica

By Angela Sormani — 3 years ago

Fabrice Egros has been appointed COO, pharmaceutical director and board member of NovaMedica. The business was established as part of the $760 million collaboration between the Russian high technology investment fund RUSNANO and the American health care venture fund Domain Associates.


Lilliputian Raises $40M From Rusnano, Intel, KP, Others

By Mark Boslet — 3 years ago

Lilliputian Systems, Inc. said it closed on $40 million of a planned $60 million equity round that was led by RUSNANO and joined by existing investors Intel Corporation, Kleiner Perkins Caufield & Byers, Altira Group, Stata Venture Partners, Atlas Venture, and Fairhaven Capital. The company makes portable fuel cell re-charger for consumer electronics.


Quantenna Raises $79M From Sequoia, RUSNANO, Bright, Others

By Mark Boslet — 4 years ago

Quantenna Communications, Inc. said it raised $79 million in a round led by RUSNANO and joined by the new investor Bright Capital. Existing investors participated, including Sequoia Capital, DAG Ventures, Sigma Partners, Southern Cross Venture Partners and Venrock Associates. RUSNANO will invest up to $40 million and Sequoia Capital Growth Fund will contribute $20 million, […]


Rusnano Joins Forces with US Venture Fund

By Reuters News — 4 years ago

Russian state technology firm Rusnano is teaming up with a US venture fund, writes Reuters. Rusnano and life sciences technologies investor Domain Associates are planning to co-invest in about 20 US-based healthcare technology companies. Rusnano will invest up to $330 million and Domain’s venture capital funds and other investors will invest a like amount, according […]


Selecta Biosciences Seals Up to $47.25M

4 years ago

Watertown, Mass.-based Selecta Biosciences Inc. has closed on up to $47.25 million financing round from investors including RUSNANO, a $10-billion Russian Federation fund. The funding will be used for research and development efforts around the company’s vaccines and immunotherapies. Selecta’s financing breaks down into a $22 million Series D, and additional funding up to $25.25 million for strategic activities in Russia, the company said.